p53 Gene and Lung Cancer
Author Information
Author(s): Papadakis E D, Soulitzis N, Spandidos D A
Primary Institution: University of Crete
Hypothesis
Is there an association between p53 codon 72 polymorphism and advanced lung cancer?
Conclusion
The study found that the p53 Arg allele is preferentially retained in lung cancer patients with the Arg/Pro genotype.
Supporting Evidence
- p53 Arg/Arg genotype was significantly increased in lung cancer patients compared to normal controls (50% vs 24.2%).
- Loss of heterozygosity at the TP53 locus was found in 51.85% of Arg/Pro patients.
- HPV was detected in only 3.7% of lung cancer patients, suggesting it does not play a significant role in lung carcinogenesis.
Takeaway
This study looked at a gene that can affect cancer risk and found that one version of the gene is more common in lung cancer patients.
Methodology
The study analyzed the genotypic frequency of p53 codon 72 polymorphism in lung cancer patients and healthy controls using PCR and microsatellite analysis.
Potential Biases
Potential selection bias due to the nature of the patient population and control group matching.
Limitations
The study was limited to a specific geographical region and population, which may affect the generalizability of the results.
Participant Demographics
54 Greek Caucasian patients with advanced lung cancer and 99 healthy Greek Caucasian controls.
Statistical Information
P-Value
<0.002
Confidence Interval
95% CI=1.46–6.73
Statistical Significance
p<0.002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website